Molly Harper - 15 Dec 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Molly Harper
Issuer symbol
CPRX
Transactions as of
15 Dec 2023
Net transactions value
-$143,620
Form type
4
Filing time
19 Dec 2023, 17:00:18 UTC
Previous filing
12 Dec 2023
Next filing
29 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $57,720 -4,000 -100% $14.43 0 15 Dec 2023 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $57,800 +10,000 $5.78 10,000 15 Dec 2023 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $143,700 -10,000 -100% $14.37 0 15 Dec 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -10,000 -7.1% $0.000000 130,764 15 Dec 2023 Common Stock 10,000 $5.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and to fund the exercise price of the stock options, and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $14.37 to $14.40 per share.
F3 Options vest in three annual tranches beginning on June 29, 2022.